CORRECTED: Serologicals Corporation Schedules Second Quarter Earnings Release and Conference Call.ATLANTA -- Serologicals Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :SERO SERO Southeast Regional Office SERO Sekundaerrohstoffe (recycling, former GDR) SERO Syringe Exchange Resources Online SERO System Engineering/Engineer Release Order SERO Site Emergency Response Organisation (nuclear) ) announced today that it will release its second quarter earnings on Wednesday, July 27, 2005 after the close of regular trading hours, and then host a conference call on Thursday, July 28, 2005 at 9:00 a.m. (ET) to review the results. The conference call dial in number is 800-291-9234, International dial-in 617-614-3923, confirmation code 67045571. The live broadcast will also be available online at the Company's website at www.serologicals.com and at www.StreetEvents.com. If you are unable to participate in the call, a 14-day playback will start July 28, 2005 at 11:00 a.m. (Eastern Time). To listen to the playback, please call 888-286-8010, International dial-in 617-801-6888, and enter access code 14006006, or access the archived web cast on the Company's website at www.serologicals.com. Serologicals Corporation (NASDAQ:SERO), headquartered in Atlanta, GA., is a global leader in developing and commercializing consumable biological products, enabling technologies and services in support of biological research, drug discovery, and the bioprocessing of life- enhancing products. Our customers include researchers at major life science companies and leading research institutions involved in key disciplines, such as neurology, oncology, hematology, immunology, cardiology, proteomics, infectious diseases infectious diseases: see communicable diseases. , cell signaling and stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research. In addition, Serologicals is the world's leading provider of monoclonal antibodies for the blood typing blood typing Classification of blood by inherited antigens associated with erythrocytes (red blood cells). The ABO blood-group system and Rh blood-group system are among those most commonly considered. industry. Serologicals employs a total of more than 1,000 people worldwide in three Serologicals' companies: Chemicon International, headquartered in Temecula, CA, Upstate Group, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , headquartered in Charlottesville, VA. and Celliance Corporation, headquartered in Atlanta, GA. Serologicals is a registered trademark of Serologicals Investment Company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion